Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Checkpoints in Solid Organ Transplantation. | Biology (Basel) | 2023 | 37887068 | PubTator, text mining | PubMed |
| Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics. | PLoS One | 2023 | 37883387 | PubTator, text mining | PubMed |
| Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. | BMC Med Genomics | 2023 | 37880682 | PubTator, text mining | PubMed |
| GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol. | PLoS One | 2023 | 37878624 | PubTator, text mining | PubMed |
| Pathologically confirmed spontaneous regression of small cell lung cancer after computed tomography-guided percutaneous transthoracic needle biopsy followed by surgery. | Surg Case Rep | 2023 | 37878146 | PubTator, text mining | PubMed |
| Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37878007 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer. | Front Genet | 2023 | 37876593 | PubTator, text mining | PubMed |
| A truncated HIV Tat demonstrates potent and specific latency reversal activity. | Antimicrob Agents Chemother | 2023 | 37874295 | PubTator, text mining | PubMed |
| Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells. | Front Immunol | 2023 | 37868997 | PubTator, text mining | PubMed |
| The role of mitochondria-related lncRNAs in characterizing the immune landscape and supervising the prognosis of osteosarcoma. | J Bone Oncol | 2023 | 37868616 | PubTator, text mining | PubMed |
| Recent advances in understanding T cell activation and exhaustion during HBV infection. | Virol Sin | 2023 | 37866815 | PubTator, text mining | PubMed |
| Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer. | J Cancer | 2023 | 37859811 | PubTator, text mining | PubMed |
| Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD. | Hepatol Commun | 2023 | 37851406 | PubTator, text mining | PubMed |
| Exploring immune related gene signatures and mechanisms linking non alcoholic fatty liver disease to atrial fibrillation through transcriptome data analysis. | Sci Rep | 2023 | 37845390 | PubTator, text mining | PubMed |
| Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia. | Cancer Drug Resist | 2023 | 37842238 | PubTator, text mining | PubMed |
| Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. | Front Immunol | 2023 | 37841237 | PubTator, text mining | PubMed |
| SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer. | Cancers (Basel) | 2023 | 37835502 | PubTator, text mining | PubMed |
| Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child-Diagnostic and Treatment Struggle. | Int J Mol Sci | 2023 | 37833906 | PubTator, text mining | PubMed |
| A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling. | Mol Ther Oncolytics | 2023 | 37829123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=12